Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/11894
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tantitamit T. | |
dc.contributor.author | U'Wais A. | |
dc.contributor.author | Huang K.-G. | |
dc.date.accessioned | 2021-04-05T03:01:24Z | - |
dc.date.available | 2021-04-05T03:01:24Z | - |
dc.date.issued | 2020 | |
dc.identifier.issn | 22133070 | |
dc.identifier.other | 2-s2.0-85089574120 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/11894 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089574120&doi=10.4103%2fGMIT.GMIT_70_18&partnerID=40&md5=128e193b1e435cb08be197bb3dbe353c | |
dc.description.abstract | We report a rare case with the late occurrence of growing teratoma syndrome (GTS). A 24-year-old woman with Grade 3 immature teratoma of ovary underwent complete surgery and chemotherapy. Nineteen years later, she developed hematuria and pelvic mass that was completely resected and pathology revealed mature cystic teratoma. She has regularly followed up with tumor marker and computed tomography every three months. No evidence of disease has been detected throughout 14 years. In addition, we present a brief review of literature of ovarian GTS in the last decade. We have found that advanced stage, high grade, or early recurrence of germ cell tumor (GCT) could be the risk factors of GTS. It tends to appear within 1 year if the patients had the incomplete resection of primary disease. We stress the importance of long-term follow-up after treatment GCT to early recognition and treatment. © 2020 Gynecology and Minimally Invasive Therapy | Published by Wolters Kluwer-Medknow. | |
dc.subject | bleomycin | |
dc.subject | cisplatin | |
dc.subject | cyclophosphamide | |
dc.subject | doxorubicin | |
dc.subject | etoposide | |
dc.subject | tumor marker | |
dc.subject | vincristine | |
dc.subject | adjuvant chemotherapy | |
dc.subject | adult | |
dc.subject | advanced cancer | |
dc.subject | Article | |
dc.subject | cancer chemotherapy | |
dc.subject | cancer surgery | |
dc.subject | case report | |
dc.subject | clinical article | |
dc.subject | cystectomy | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | frozen section | |
dc.subject | growing teratoma syndrome | |
dc.subject | hematuria | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | hydronephrosis | |
dc.subject | hydroureter | |
dc.subject | hysterectomy | |
dc.subject | multiple cycle treatment | |
dc.subject | ovary teratoma | |
dc.subject | priority journal | |
dc.subject | salpingooophorectomy | |
dc.subject | x-ray computed tomography | |
dc.subject | young adult | |
dc.title | An ultralate female growing teratoma syndrome: 19 years after aggressive treatment for advanced ovarian immature teratoma | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Gynecology and Minimally Invasive Therapy. Vol 9, No.3 (2020), p.150-153 | |
dc.identifier.doi | 10.4103/GMIT.GMIT_70_18 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.